Ergoresearch, Montreal, Quebec, Canada, has announced its results for the second quarter of 2010. During the period in question, sales reached approximately CAN$1.629 million, compared to CAN$1.617 million for the same period last year. It also recorded an increase of its sales for the first six months of the 2010 fiscal year, climbing to CAN$3.225 million from CAN$2.229 million at the same period last year, representing a 44.6 percent increase.
“We are satisfied with the results of this second quarter of 2010,” Sylvain Boucher, Ergoresearch president and CEO, stated in a press release. “Notwithstanding challenging economic times and the climate of uncertainty and disorganization that characterized the early stages of the swine flu vaccination campaign in Quebec (which probably resulted in a decrease in the number of patients in the clinics), the company very successfully integrated its most recent acquisition…. Such noteworthy improvements stand witness to the hard work of our employees, management team, and directors. All have rallied around a common strategy and provided their best efforts to allow the company to reach summiting performances.”
